Less Ads, More Data, More Tools Register for FREE

Pin to quick picks96ES.L Regulatory News (96ES)

  • There is currently no data for 96ES

Director effectiveness assessment

13 Feb 2020 07:00

RNS Number : 8370C
Barclays PLC
13 February 2020
 

 

13 February 2020

Barclays PLCBarclays Bank PLC

Director effectiveness assessment: disclosure of regulatory investigation

In accordance with the UK Corporate Governance Code, all of the current Directors of Barclays PLC will be submitting themselves for election or re-election at the Annual General Meeting to be held on 7 May 2020, and will be unanimously recommended by the Board for election or re-election as appropriate. Further information in this regard will be set out in the Notice of Meeting which will be published in due course.

In deciding whether to recommend Jes Staley for re-election, the Board has carried out its usual formal and rigorous performance assessment, which it does in respect of the effectiveness of each of the Directors. As part of its determination in respect of Mr. Staley, the Board has had regard to media reports in the past 6 months that have highlighted historical links between Mr. Staley and Jeffrey Epstein.

As has been widely reported, earlier in his career Mr. Staley developed a professional relationship with Mr. Epstein. In the summer of 2019, in light of the renewed media interest in the relationship, Mr. Staley volunteered and gave to certain executives, and the Chairman, an explanation of his relationship with Mr. Epstein. Mr. Staley also confirmed to the Board that he has had no contact whatsoever with Mr. Epstein at any time since taking up his role as Barclays Group CEO in December 2015.

The relationship between Mr. Staley and Mr. Epstein was the subject of an enquiry from the Financial Conduct Authority ("FCA"), to which the Company responded. The FCA and the Prudential Regulation Authority subsequently commenced an investigation, which is ongoing, into Mr. Staley's characterisation to the Company of his relationship with Mr. Epstein and the subsequent description of that relationship in the Company's response to the FCA.

Based on a review, conducted with the support of external counsel, of the information available to us and representations made by Mr. Staley, the Board (the Executive Directors having been recused) believes that Mr. Staley has been sufficiently transparent with the Company as regards the nature and extent of his relationship with Mr. Epstein. Accordingly, Mr. Staley retains the full confidence of the Board, and is being unanimously recommended for re-election at the Annual General Meeting.

The Board will continue to cooperate fully with the regulatory investigation, and will provide a further update as and when it is appropriate to do so.

- ENDS -

For further information, please contact:

Investor Relations

Media Relations

Adam Strachan

Tom Hoskin

+1 212 526 8442

+44 (0) 20 7116 4755

James Johnson 

+44 (0)20 7116 7233

 

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Group.

For further information about Barclays, please visit our website home.barclays 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLLLFBLLBBBB
Date   Source Headline
20th Feb 20193:05 pmRNSNotice to Noteholders-Series 11492 Class MF
29th Jan 201911:03 amRNSWithdrawal of Notes
9th Jan 20193:29 pmRNSPublication of Final Terms
18th Dec 20185:05 pmRNSConsent order re Barclays Whistleblowing programme
18th Dec 20185:00 pmRNSNotice to Noteholders Series 11492 Class LP
18th Dec 201811:13 amRNSPublication of Final Terms
13th Dec 20187:00 amRNSResults of Placing of Gamma Communications Shares
12th Dec 20184:50 pmRNSProposed Placing of Gamma Communications Shares
12th Dec 20183:17 pmRNSPublication of Final Terms
30th Nov 201812:07 pmRNSPublication of Final Terms
20th Nov 201812:43 pmRNSPublication of Suppl.Prospcts
20th Nov 201812:41 pmRNSPublication of a Prospectus
19th Nov 20181:22 pmRNSPublication of Final Terms
14th Nov 20184:30 pmRNSPublication of Suppl.Prospcts
12th Nov 20184:56 pmRNSPublication of Suppl.Prospcts
31st Oct 20184:30 pmRNSPublication of Suppl.Prospcts
31st Oct 201812:51 pmRNSOctober Announcement
24th Oct 20187:00 amRNSRedemption Notice
19th Oct 201812:49 pmRNSDublin Bay Securities 2018-MA1 DAC Announcement
11th Oct 20186:02 pmRNSPublication of a Prospectus
11th Oct 20185:29 pmRNSMet Life Post-Stabilisation Notice
11th Oct 20185:28 pmRNSSkipton Post-Stabilisation Notice
11th Oct 20185:21 pmRNSBBVA Post Stabilisation Notice
2nd Oct 20188:30 amRNSMet Life Pre-Stabilisation Notice
28th Sep 20185:18 pmRNSDelisting Notice
28th Sep 20183:51 pmRNSPublication of Final Terms
25th Sep 20188:39 amRNSSkipton Pre- Stabilisation Notice
18th Sep 20188:40 amRNSBBVA pre Stabilisation Notice
11th Sep 20184:10 pmRNSCapital Reorganisation
5th Sep 20187:00 amRNSResults of Placing of Sabre Insurance Group Shares
4th Sep 20184:50 pmRNSProposed Placing of Sabre Insurance Group Shares
3rd Sep 201812:07 pmRNSPost Stabilisation Notice - Barclays PLC
24th Aug 20189:21 amRNSStabilisation Notice
21st Aug 201810:15 amRNSPublication of Suppl.Prospcts
21st Aug 201810:14 amRNSPublication of Suppl.Prospcts
14th Aug 20186:15 pmRNSPublication of Suppl.Prospcts
14th Aug 201811:30 amRNSPublication of Suppl.Prospcts
9th Aug 20187:44 amRNSForm 6-K
3rd Aug 20184:00 pmRNSPublication of Suppl.Prospcts
2nd Aug 20187:00 amRNSHalf-year Report
24th Jul 201810:02 amRNSSFO seeks to reinstate charges against Barclays
15th Jun 20183:06 pmRNSUpdate re: Barclays
15th Jun 201810:11 amRNSPublication of GSSP Base Prospectus 5
31st May 20185:17 pmRNSPublication of Supplement 5/2017 to the GSSP BPs
30th May 20187:00 amRNSResults of Placing of Sabre Insurance Group Shares
29th May 20185:01 pmRNSProposed Placing of Sabre Insurance Group Shares
24th May 20186:20 pmRNSPublication of Suppl.Prospcts
21st May 20184:58 pmRNSCMCIC Post-Stabilisation Notice
21st May 201811:08 amRNSDismissal of SFO charges re 2008 capital raisings
11th May 201812:15 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.